BioVaxys Technology Corp. (BVAXF)
OTC
0.1100
+0.0078 (+7.63%)
Closed
Oct 6, 2026
Day's Range
0.10220.1379
52 wk Range
0.02090.2280
Financial Statements - BVAXF - BioVaxys Technology Corp.
Revenue
0
Net Income
-3.95M▲ 48.6%
EBITDA
-2.63M▲ 49.2%
Free Cash Flow
-2.91M▼ 176.7%
Income Statement
| Period Ending | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | 2020-10-31 | 2019-10-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -3.29M | -6.45M | -4.08M | -6.44M | -1.09M | -216.67K |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -659.26K | -1.25M | -7.66M | -23.56K | -4.37K | -209 |
| Pre Tax Income | -3.95M | -7.68M | -11.72M | -6.45M | -1.10M | -216.88K |
| Income Tax | - | - | - | - | - | - |
| Net Income | -3.95M | -7.68M | -11.72M | -6.45M | -1.17M | -230.12K |
| EPS Basic | -0.2 | -0.6 | -0.12 | -0.08 | -0.042 | -0.022 |
| EPS Diluted | -0.2 | -0.6 | -0.12 | -0.08 | -0.042 | -0.022 |
| Basic Shares Outstanding | 19.57M | 13.41M | 139.80M | 118.09M | 40.17M | 14.78M |
| Diluted Shares Outstanding | 19.57M | 13.41M | 139.80M | 118.09M | 40.17M | 14.78M |
| Ebit | -3.29M | -6.45M | -4.08M | -6.44M | -1.09M | -216.67K |
| Ebitda | -2.63M | -5.19M | 3.57M | -6.41M | -1.09M | -216.46K |
| Net Income Continuous Operations | -3.95M | -7.68M | -11.72M | -6.45M | -1.10M | -216.88K |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
